RxSight, Inc.
RxSight, Inc. (RXST) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RXST · as of Jun 8, 2026
Key Statistics
Explore RxSight, Inc. Data
rxst stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 25.0%
The RXST analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $10.33, representing +108.69% upside from the current price of $4.95.
Competitors & Peers
rxst competitorsRXST
BFLY
CERS
DCTH
DMAC
KIDSStock Performance
Full HistoryAbout RxSight, Inc.
RxSight, Inc. As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light…
what is rxsight, inc. · rxst stock overview · rxsight, inc. company profile · who is rxsight, inc. ceo · rxst NASDAQ · rxsight, inc. headquarters · rxsight, inc. business segments
About Stock Overview & Key Data
RxSight, Inc. (RXST) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 30, 2021. As of the latest trading session, RXST stock price is $4.95, with a market capitalization of $204.9M. The stock has returned -67.65% over the past 12 months and -52.50% year-to-date.
According to 12 Wall Street analysts, the consensus rating for RxSight, Inc. stock is Hold, with an average 12-month price target of $10.33. In fiscal year 2025, RxSight, Inc. reported revenue of $134.5M and net income of -$38.9M. For detailed data — including RxSight, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, RxSight, Inc. (RXST) stock price is $4.95. The stock is traded on NASDAQ under the ticker symbol RXST. The 52-week range is $4.70 – $16.00.